Artelo Biosciences ARTL
NASDAQ ARTL
$2.18 +0.04 (+1.76%)
As of: Nov 11, 2026 · 3:59 PM EST

Artelo Biosciences (ARTL) Interest Expenses (2017 - 2026)

Updated

Analysis

Artelo Biosciences (ARTL) Interest Expenses (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 217.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Artelo Biosciences 49.32 Mn 32.53 Mn - -6,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6,000.00
Mar 31, 2026 100,000.00
Dec 31, 2025 11,000.00
Sep 30, 2025 111,000.00
Jun 30, 2025 72,000.00
Sep 30, 2022 5,000.00
Nov 30, 2019 586,000.00
Aug 31, 2017 177.00
May 31, 2017 907.00
Feb 28, 2017 1,016.00
API Access

Artelo Biosciences Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=ARTL&period=max&api_key=YOUR_API_KEY